Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by kdog1caon Feb 26, 2021 6:25pm
256 Views
Post# 32677088

RE:Any relation between Sanotize & Kly(Claritas)?

RE:Any relation between Sanotize & Kly(Claritas)?SaNOtize from BC is a privately held company doing phase 2 studies on Nitic Oxide nasal spray right now. In the UK. They have one investor. Their CEO is Israeli Gilly REGEV, the head of their board of directors is Israeli Dr. Ferid Murad who won the nobel prize for his work in Nitric Oxide. Nitric Oxide is already FDA approved so this could ramp up quickly. 

Back in early February on LinkedIn, a company called Nextar Chempharma Solutions Inc.announced they had taken receipt of the equipment to mass produce this Nasal spray so they are preparing to commercialize on a large scale in Weizzman Science Park, Israel.  Remember though, SaNOtize is a private company, they would need a publicly traded company to potentially licence / partner with rather than go through the trouble of bringing it to an exchange. Claritas (Kalytera) has an Israeli connection as well and has a patent on the pill form and nasal spray and are also getting Salzman ' s naproxen/ CBD conjugate too. Andrew Salzman is on the Claritas team as well and is listed as a Scientific Advisor.

V.KLY is set to explode next week! SaNOtize could be left in the dust here...
<< Previous
Bullboard Posts
Next >>